Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
miDiagnostics logo — Rapid lab-quality diagnostics for everyone, anywhere and at...

miDiagnostics

Rapid lab-quality diagnostics for everyone, anywhere and at anytime

Founded 2015 Belgium Belgium 57 employees Debt Financing Total: $35.70M Health Care

General Information

Company Name miDiagnostics
Founded Year 2015
Location Belgium Belgium
Employees 57
Industries Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with miDiagnostics. To contact miDiagnostics, visit midiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does miDiagnostics compare?

A PDF of miDiagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting miDiagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About miDiagnostics

miDiagnostics is a Belgium-based startup founded in 2015 with the aim of revolutionizing medical diagnostics. The company's slogan, "miDiagnostics is creating a device for easy detection from a few drops of blood," encapsulates its core mission. The advanced diagnostic system developed by miDiagnostics leverages a silicon nanofluidic processor, enabling the development of disposable tests that necessitate only a small volume of blood for the detection of cells, proteins, nucleic acids, and small molecules. This innovative approach holds the potential to streamline and simplify the diagnostic process, enhancing accessibility and efficiency in healthcare. The latest milestone in miDiagnostics' journey is the €20.00M Debt Financing investment secured on 09 December 2021, with the European Investment Bank (EIB) participating as the investor. This injection of funds is expected to propel miDiagnostics towards further advancements and broader implementation of its groundbreaking technology, positioning the company as a key player in the evolving landscape of medical diagnostics.

Business keywords: medical diagnostics, blood testing, nanofluidic technology, disposable tests, precision medicine, biosensors, point-of-care testing, nanotechnology, biomedical devices

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing €20.00M 1
European Investment Bank
09 Dec 2021
Venture Round €14.00M 2
Rudi Pauwels, Urbain Vandeurzen
26 Mar 2020
Grant €1.70M -
01 Oct 2018
Series A Undisclosed -
01 Dec 2017

Latest News

View All
Belgium’s bold tech revolution at the heart of Europe — Tech
Belgium’s bold tech revolution at the heart of Europe
Tech Nov 23, 2025

miDiagnostics Alternatives & Competitors

View All Alternatives
miDiagnostics vs
LamdaGen Corporation
LamdaGen Corporation United States

Unlocking the potential of advanced nanotechnologies

Grant
6 employees
Biotechnology, Health Care
Compare miDiagnostics vs LamdaGen Corporation
miDiagnostics vs
Ativa
Ativa United States

Decoding Blood, Changing Care.

Venture round
20 employees
Biotechnology, Health Care
Compare miDiagnostics vs Ativa
miDiagnostics vs
Hememics Biotechnologies, Inc.
Hememics Biotechnologies, Inc. United States

Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld,...

Seed
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About miDiagnostics

Rapid lab-quality diagnostics for everyone, anywhere and at anytime
miDiagnostics was founded in 2015.
miDiagnostics is headquartered in Belgium.
miDiagnostics operates in Health Care. Its work centres on medical diagnostics, blood testing, nanofluidic technology and disposable tests.
miDiagnostics has approximately 57 employees.
miDiagnostics has completed 4 funding rounds, raising a total of $35.70M. The latest funding stage is Debt Financing.
Top alternatives and competitors to miDiagnostics include LamdaGen Corporation, Ativa, Hememics Biotechnologies, Inc., Haemokinesis, Vidcare Innovations. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
miDiagnostics and LamdaGen Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for miDiagnostics, https://bouncewatch.com/company/midiagnostics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes